The EGFR protein expression and the gene copy number changes in renal cell carcinomas

Sangho Lee, Jungsuk An, Aeree Kim, Young Sik Kim, Insun Kim

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: The epidermal growth factor receptor (EGFR) is known to be involved in many tumor promoting activities. EGFR inhibition has been tried as a therapeutic modality in many human malignancies. Methods: The expression of EGFR protein and the gene copy number changes were studied in 135 clear cell carcinomas and 16 papillary renal cell carcinomas (RCCs), and these tumors were diagnosed between 1995 and 1997. Results: An EGFR protein expression (2+ and 3+) was found in 54.1% of the clear cell RCCs and in 43.8% of the papillary RCCs. In the clear cell RCCs, its expression was associated with male gender, the tumor size (≥4 cm) and high T stages (T2 and T3), with statistical significance. Trisomy and polysomy of the EGFR gene were found in 27 (25.7%) and 40 (38.1%) of 105 clear cell RCCs, respectively. Trisomy and polysomy were correlated with an EGFR protein expression and a high clinical T stage, with statistical significance. Among 15 papillary RCCs, 13 tumors showed trisomy (86.7%) and one showed polysomy (6.7%). Amplification was not found in both the clear cell and papillary type RCCs. Conclusions: A considerable numbers of RCCs showed an overexpression of EGFR protein and increased EGFR gene copy numbers, yet the clinical significance of conducting a FISH study in RCC patients seems to be limited.

Original languageEnglish
Pages (from-to)413-419
Number of pages7
JournalKorean Journal of Pathology
Volume43
Issue number5
DOIs
Publication statusPublished - 2009 Oct 1

Fingerprint

Gene Dosage
Renal Cell Carcinoma
Epidermal Growth Factor Receptor
Proteins
erbB-1 Genes
Trisomy
Neoplasms
Carcinoma

Keywords

  • Epidermal growth factor receptor
  • Fluorescence in situ hybridization
  • Ploidies
  • Renal cell carcinoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

The EGFR protein expression and the gene copy number changes in renal cell carcinomas. / Lee, Sangho; An, Jungsuk; Kim, Aeree; Kim, Young Sik; Kim, Insun.

In: Korean Journal of Pathology, Vol. 43, No. 5, 01.10.2009, p. 413-419.

Research output: Contribution to journalArticle

@article{06acf284a6eb4abc85b1ad4f5a3492b0,
title = "The EGFR protein expression and the gene copy number changes in renal cell carcinomas",
abstract = "Background: The epidermal growth factor receptor (EGFR) is known to be involved in many tumor promoting activities. EGFR inhibition has been tried as a therapeutic modality in many human malignancies. Methods: The expression of EGFR protein and the gene copy number changes were studied in 135 clear cell carcinomas and 16 papillary renal cell carcinomas (RCCs), and these tumors were diagnosed between 1995 and 1997. Results: An EGFR protein expression (2+ and 3+) was found in 54.1{\%} of the clear cell RCCs and in 43.8{\%} of the papillary RCCs. In the clear cell RCCs, its expression was associated with male gender, the tumor size (≥4 cm) and high T stages (T2 and T3), with statistical significance. Trisomy and polysomy of the EGFR gene were found in 27 (25.7{\%}) and 40 (38.1{\%}) of 105 clear cell RCCs, respectively. Trisomy and polysomy were correlated with an EGFR protein expression and a high clinical T stage, with statistical significance. Among 15 papillary RCCs, 13 tumors showed trisomy (86.7{\%}) and one showed polysomy (6.7{\%}). Amplification was not found in both the clear cell and papillary type RCCs. Conclusions: A considerable numbers of RCCs showed an overexpression of EGFR protein and increased EGFR gene copy numbers, yet the clinical significance of conducting a FISH study in RCC patients seems to be limited.",
keywords = "Epidermal growth factor receptor, Fluorescence in situ hybridization, Ploidies, Renal cell carcinoma",
author = "Sangho Lee and Jungsuk An and Aeree Kim and Kim, {Young Sik} and Insun Kim",
year = "2009",
month = "10",
day = "1",
doi = "10.4132/KoreanJPathol.2009.43.5.413",
language = "English",
volume = "43",
pages = "413--419",
journal = "Journal of Pathology and Translational Medicine",
issn = "2383-7837",
publisher = "Korean Society of Pathologists",
number = "5",

}

TY - JOUR

T1 - The EGFR protein expression and the gene copy number changes in renal cell carcinomas

AU - Lee, Sangho

AU - An, Jungsuk

AU - Kim, Aeree

AU - Kim, Young Sik

AU - Kim, Insun

PY - 2009/10/1

Y1 - 2009/10/1

N2 - Background: The epidermal growth factor receptor (EGFR) is known to be involved in many tumor promoting activities. EGFR inhibition has been tried as a therapeutic modality in many human malignancies. Methods: The expression of EGFR protein and the gene copy number changes were studied in 135 clear cell carcinomas and 16 papillary renal cell carcinomas (RCCs), and these tumors were diagnosed between 1995 and 1997. Results: An EGFR protein expression (2+ and 3+) was found in 54.1% of the clear cell RCCs and in 43.8% of the papillary RCCs. In the clear cell RCCs, its expression was associated with male gender, the tumor size (≥4 cm) and high T stages (T2 and T3), with statistical significance. Trisomy and polysomy of the EGFR gene were found in 27 (25.7%) and 40 (38.1%) of 105 clear cell RCCs, respectively. Trisomy and polysomy were correlated with an EGFR protein expression and a high clinical T stage, with statistical significance. Among 15 papillary RCCs, 13 tumors showed trisomy (86.7%) and one showed polysomy (6.7%). Amplification was not found in both the clear cell and papillary type RCCs. Conclusions: A considerable numbers of RCCs showed an overexpression of EGFR protein and increased EGFR gene copy numbers, yet the clinical significance of conducting a FISH study in RCC patients seems to be limited.

AB - Background: The epidermal growth factor receptor (EGFR) is known to be involved in many tumor promoting activities. EGFR inhibition has been tried as a therapeutic modality in many human malignancies. Methods: The expression of EGFR protein and the gene copy number changes were studied in 135 clear cell carcinomas and 16 papillary renal cell carcinomas (RCCs), and these tumors were diagnosed between 1995 and 1997. Results: An EGFR protein expression (2+ and 3+) was found in 54.1% of the clear cell RCCs and in 43.8% of the papillary RCCs. In the clear cell RCCs, its expression was associated with male gender, the tumor size (≥4 cm) and high T stages (T2 and T3), with statistical significance. Trisomy and polysomy of the EGFR gene were found in 27 (25.7%) and 40 (38.1%) of 105 clear cell RCCs, respectively. Trisomy and polysomy were correlated with an EGFR protein expression and a high clinical T stage, with statistical significance. Among 15 papillary RCCs, 13 tumors showed trisomy (86.7%) and one showed polysomy (6.7%). Amplification was not found in both the clear cell and papillary type RCCs. Conclusions: A considerable numbers of RCCs showed an overexpression of EGFR protein and increased EGFR gene copy numbers, yet the clinical significance of conducting a FISH study in RCC patients seems to be limited.

KW - Epidermal growth factor receptor

KW - Fluorescence in situ hybridization

KW - Ploidies

KW - Renal cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=77951178476&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951178476&partnerID=8YFLogxK

U2 - 10.4132/KoreanJPathol.2009.43.5.413

DO - 10.4132/KoreanJPathol.2009.43.5.413

M3 - Article

AN - SCOPUS:77951178476

VL - 43

SP - 413

EP - 419

JO - Journal of Pathology and Translational Medicine

JF - Journal of Pathology and Translational Medicine

SN - 2383-7837

IS - 5

ER -